NOVEL ISOINDOL DERIVATIVES AS EP4 RECEPTOR AGONISTS
A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, R1, R2, R3, R4 and R5, X and Y are as defined in the specification; a process for preparing such compounds; a ph
-
Page/Page column 38
(2008/06/13)
More Articles about upstream products of 1007220-40-7